Mirae Asset Global ETFs Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25M	Buy	411,657 +54,063	+15%	+$3.15M	0.03%	424
2025 Q4	$19.3M	Sell	357,594 -25,155	-7%	-$1.21M	0.03%	470
2025 Q3	$17.2M	Sell	382,749 -320,879	-46%	-$15M	0.03%	484
2025 Q2	$32.6M	Buy	703,628 +435,899	+163%	+$21.4M	0.06%	289
2025 Q1	$16.3M	Sell	267,729 -17,191	-6%	-$1M	0.03%	444
2024 Q4	$16.1M	Sell	284,920 -3,042	-1%	-$170K	0.03%	429
2024 Q3	$14.9M	Sell	287,962 -20,785	-7%	-$975K	0.03%	435
2024 Q2	$12.8M	Buy	+308,747	New	+$13.8M	0.03%	464

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BMY Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Bristol-Myers Squibb (BMY) stake by 15% in Q1 2026, buying an estimated $3.15M and bringing the position to 411,657 shares worth $25M. The position accounts for 0.03% of the portfolio, ranked #424.

Mirae Asset Global ETFs Holdings first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $32.6M in Q2 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Mirae Asset Global ETFs Holdings held 411,657 shares of Bristol-Myers Squibb worth $25M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 54,063 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.15M.
Bristol-Myers Squibb made up 0.03% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #424 holding.
Mirae Asset Global ETFs Holdings first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Bristol-Myers Squibb position peaked at $32.6M in Q2 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.